Tanvex BioPharma, Inc. (6541.TW) TAI
41.20
-0.65(-1.55%)
Currency In TWD
- General
- Statistics
- Historical Data
- Profile
- Financials
Tanvex BioPharma, Inc.
Address
802 West Bay Road
George Town, KY1-1205
Cayman Islands (the)
Phone
+886 2 2655 8080
Website
Sector
Healthcare
Industry
Biotechnology
Employees
139
First IPO Date
August 13, 2015
Key Executives
| Name | Title | Pay | Year Born |
| Stephen Lam | Chief Executive Officer & Director | 0 | N/A |
| Allen Y. Chao | Founder & Honorary Chairman | 20,000 | 1946 |
| John R. Mosack | Chief Operating Officer of US | 0 | N/A |
| Val Chen | Vice President of Finance, Director of Operations. Management & Corporate Governance Officer | 0 | N/A |
| Linda Grillo | Director of Sales & Marketing | 0 | N/A |
| Angela Luan | Chief Financial Officer & Corporate Governance Officer | 0 | N/A |
| James Williamson | Chief Accounting Officer | 0 | N/A |
| Zheng Xia | Chief Technology Officer | 0 | N/A |
| Miguel Carrion | Vice President of R&D - USA | 0 | N/A |
| Marc Goemans | Chief Commercial Officer | 0 | N/A |
Description
Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar in Taiwan and the United States. The company focuses on delivering biosimilars which target neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. Its products pipeline includes TX01 and TX-05 which have completed Phase III clinical trials; TX-04 and TX-16 that are in Phase I clinical trial; and TX-52 and other products which are in pre-clinical trial. The company was formerly known as Ruenvex Biotech, Inc. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands.
